Aziz Asphahani, Ph.D. Quotient Pharmaceuticals Manufacturing Scientific Advisory Board
Foremost authority in materials science, metallurgy, and corrosion
Immense knowledge pertaining to the elemental effects of grain-boundary degradation and molecular-binding affinity and potential; directly corresponds to the immunological antibody-specific chemistry efforts of Quotient
Long-spanning career of transforming technologies into successful new products - most recently served as CEO of Carus Chemical Company.
Former President of Cabval - increased revenue by 193 percent and EBITDA by 300 percent in the first five years